Prosecution Insights
Last updated: April 19, 2026

Morphosys AG

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18261376 ANTI-CD38 ANTIBODIES AND THEIR USES DRISCOLL, MAUREEN VARINA 1644 Non-Final OA Jul 13, 2023
17434465 ANTI-CD38 ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF AUTOANTIBODY-MEDIATED AUTOIMMUNE DISEASE GUSTILO, ESTELLA M 1646 Final Rejection Aug 27, 2021
17298156 ANTIBODY FORMULATIONS SHOMER, ISAAC 1612 Non-Final OA May 28, 2021

Managing Morphosys AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month